507264-68-8

Basic information

• Product Name: Carbamic acid, (1-cyanocyclopropyl)-, 1,1-dimethylethyl ester (9CI)
• Synonyms: Carbamic acid, (1-cyanocyclopropyl)-, 1,1-dimethylethyl ester (9CI);1-Aminocyclopropane-1-carbonitrile, N-BOC protected;tert-Butyl (1-cyanocycloprop-1-yl)carbamate, 1-[(tert-Butoxycarbonyl)amino]-1-cyanocyclopropane;(1-Cyano-Cyclopropyl)-Carbamic Acid Tert-Butyl Ester;tert-butyl 1-cyanocyclopropylcarbamate;(1-Cyano-Cyclopropyl)-Carbamic Acid Tert-Butyl Ester(WX683084)
• CAS NO: 507264-68-8
• Molecular Formula: C9H14N2O2
• Molecular Weight: 182.21966
• Product Categories: N-BOC
• Mol File: 507264-68-8.mol

Chemical Properties

• Boiling Point: 316.3±21.0 °C(Predicted)
• Appearance: /
• Density: 1.10±0.1 g/cm3(Predicted)
• PKA: 9.79±0.20(Predicted)
• CAS DataBase Reference: Carbamic acid, (1-cyanocyclopropyl)-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (1-cyanocyclopropyl)-, 1,1-dimethylethyl ester (9CI)(507264-68-8)
• EPA Substance Registry System: Carbamic acid, (1-cyanocyclopropyl)-, 1,1-dimethylethyl ester (9CI)(507264-68-8)

Safety Data

• Hazardous Substances Data: 507264-68-8(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 127946-77-4 1-amino-1-cyclopropanecarbonitrile hydrochloride 
• 507264-66-6 tert-butyl N-(1 -carbamoylcyclopropyl)carbamate 
• 196311-65-6 1-aminocyclopropanecarbonitrile 
• 88950-64-5 1-<(tert-butyloxy)carbonylamino>cyclopropane-1-carboxylic acid 

Downstream Products

• 196311-65-6 1-aminocyclopropanecarbonitrile 
• 1159734-40-3 (1-pyrimidin-2-ylcyclopropyl)carbamic acid tert-butyl ester 

Relevant articles and documents

INHIBITORS OF KEAP1-Nrf2 PROTEIN-PROTEIN INTERACTION

Sultam compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with the KEAP1-Nrf2 interaction, such as inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

Optimization strategy of single-digit nanomolar cross-class inhibitors of mammalian and protozoa cysteine proteases

Cysteine proteases (CPs) are involved in a myriad of actions that include not only protein degradation, but also play an essential biological role in infectious and systemic diseases such as cancer. CPs also act as biomarkers and can be reached by active-

Design, synthesis and antibacterial activity studies of novel quinoline carboxamide derivatives

A series of novel quinoline-6-carboxamides and 2-chloroquinoline-4- carboxamides were synthesized by the reaction of their analogous carboxylic acids with various amine derivatives in the presence of base TEA and protecting agent BOP at room temperature.

Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C

A series of dipeptide nitriles with a thienyl alanine in P2 were identified as potent and selective cathepsin C inhibitors. Incorporation of a substituted cyclopropyl moiety in P1 effectively protects these derivatives against hydrolase activity in whole blood.

DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3- CARBOXYLIC ACID AMIDES

Derivatives of 6,7-dihydro-5H-imidazo[1,2-α]imidazole-3-carboxylic acid amide exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.